Search results for "Brief Psychiatric Rating Scale"

showing 10 items of 15 documents

Computerized brain tomography measures compared with spontaneous and suppressed plasma cortisol levels in major depression.

1989

We determined brain density and ventricular measurements with computerized tomography (CT) in 33 depressed patients and compared the results with basal plasma cortisol and its suppressibility by dexamethasone. Mean plasma cortisol was positively related to elevated ventricular brain ratio (VBR). No association could be found between dexamethasone suppression test (DST) status and VBR or any other CT parameter. Elevated plasma cortisol levels and increased VBRs were positively correlated with total scores on the Brief Psychiatric Rating Scale, the Global Assessment Scale and the Bech-Rafaelsen Melancholia Scale, but they were not significantly correlated with total score on the Hamilton Anxi…

AdultMalemedicine.medical_specialtyHydrocortisoneEndocrinology Diabetes and MetabolismDexamethasoneCerebral VentriclesBasal (phylogenetics)EndocrinologyInternal medicineMelancholiaBrief Psychiatric Rating ScalemedicineHumansBiological PsychiatryDexamethasoneDepression (differential diagnoses)HydrocortisonePsychiatric Status Rating ScalesDepressive DisorderEndocrine and Autonomic SystemsBrainMiddle AgedVentricular-brain ratioPsychiatry and Mental healthEndocrinologyDexamethasone suppression testFemalemedicine.symptomPsychologyTomography X-Ray Computedmedicine.drugPsychoneuroendocrinology
researchProduct

Light exposure patterns in schizophrenia

1992

Spontaneous light exposure patterns were studied in 10 chronic schizophrenic patients. Half of our schizophrenic patients exposed themselves to bright light exceeding ordinary indoor illumination. There was a significant positive correlation between the percentage of exposure to bright light and the Brief Psychiatric Rating Scale subscore anergia and a significant negative correlation with depression.

AdultMalemedicine.medical_specialtyPsychosisAnxietyAudiologySocial EnvironmentArousalSchizophrenic PsychologyBrief Psychiatric Rating ScalemedicineHumansPsychiatryLightingDepression (differential diagnoses)AgedLight exposurePsychiatric Status Rating ScalesDepressionMiddle Agedmedicine.diseaseHospitalizationPsychiatry and Mental healthSchizophreniaSchizophreniaSchizophrenic PsychologyArousalPsychologyBright lightActa Psychiatrica Scandinavica
researchProduct

Increased amygdala and parahippocampal gyrus activation in schizophrenic patients with auditory hallucinations: An fMRI study using independent compo…

2010

Objective: Hallucinations in patients with schizophrenia have strong emotional connotations. Functional neuroimaging techniques have been widely used to study brain activity in patients with schizophrenia with hallucinations or emotional impairments. However, few of these Studies have investigated the association between hallucinations and emotional dysfunctions using an emotional auditory paradigm. Independent component analysis (ICA) is an analysis method that is especially useful for decomposing activation during complex cognitive tasks in which multiple operations occur simultaneously. Our aim in this Study is to analyze brain activation after the presentation of emotional auditory stim…

AdultMalePsychosisFACIAL EXPRESSIONSHallucinationsBrain activity and meditationDIFFERENTIAL NEURAL RESPONSENEUROBIOLOGYFEARFUL FACESIndependent component analysisAuditory hallucinationsAmygdalaSeverity of Illness IndexPSYCHOSISFunctional neuroimagingBrief Psychiatric Rating ScalemedicineEMOTIONHumansBRAINBiological PsychiatryAuditory hallucinationSALIENCEmedicine.diagnostic_testABNORMALITIESfMRIRECOGNITIONmedicine.diseaseAmygdalaMagnetic Resonance ImagingAuditory emotional paradigmPsychiatry and Mental healthmedicine.anatomical_structureSchizophreniaParahippocampal Gyrusmedicine.symptomPsychologyFunctional magnetic resonance imagingBrain activityNeuroscienceParahippocampal gyrus
researchProduct

Dose-Related Effects of Amisulpride on Five Dimensions of Psychopathology in Patients With Acute Exacerbation of Schizophrenia

2002

The present analysis investigated symptom-specific dose-response relationships of the atypical antipsychotic amisulpride (AMI) in schizophrenic patients. The effects of different AMI doses on five different symptom dimensions of the Brief Psychiatric Rating Scale (BPRS) were analyzed. Results on global efficacy and safety parameters have been previously published. Four AMI doses (100 mg/day [AMI100], 400 mg/day [AMI400], 800 mg/day [AMI800], 1200 mg/day) were compared with 16 mg haloperidol (HAL16) in a multicenter, double-blind, randomized, parallel-group, 4-week trial. A total of 319 patients with acute exacerbation of schizophrenia (DSM-III-R) were included. AMI100 was compared with the …

AdultMalemedicine.medical_specialtyAdolescentExacerbationmedicine.drug_classmedicine.medical_treatmentAtypical antipsychoticInternal medicineBrief Psychiatric Rating ScalemedicineHaloperidolHumansPharmacology (medical)AmisulpridePsychiatryAntipsychoticPsychiatric Status Rating ScalesDose-Response Relationship DrugDopamine antagonistMiddle AgedPsychiatry and Mental healthTreatment OutcomeSchizophreniaHaloperidolAnxietyFemaleSchizophrenic PsychologyAmisulprideSulpiridemedicine.symptomPsychologyAntipsychotic Agentsmedicine.drugJournal of Clinical Psychopharmacology
researchProduct

Differential effects of high-dose amisulpride versus flupentixol on latent dimensions of depressive and negative symptomatology in acute schizophreni…

2002

While many acutely ill schizophrenic patients suffer from depressive symptoms, most studies on the efficacy of antipsychotic drugs focus on positive and negative symptoms. Dimensional models of schizophrenic symptoms, based on confirmatory factor analysis (CFA) using structural equation modelling, offer a methodological alternative to compare antipsychotics on empirically justified latent factors. The present report is a refined analysis of a published double-blind study on the D 2 /D 3 -selective antagonist amisulpride (ASP) versus the mixed D 1-5 /5-HT 2 antagonist flupentixol (FPX). CFA was applied to Brief Psychiatric Rating Scale, Scale for the Assessment of Negative Symptoms, Bech-Raf…

AdultMalemedicine.medical_specialtyAdolescentmedicine.medical_treatmentDouble-Blind MethodBrief Psychiatric Rating ScalemedicineHumansPharmacology (medical)AmisulprideAntipsychoticPsychiatryScale for the Assessment of Negative SymptomsAgedMiddle Agedmedicine.diseaseConfirmatory factor analysisFlupentixolFlupenthixolPsychiatry and Mental healthAffectPsychotropic drugSchizophreniaSchizophreniaFemaleSchizophrenic PsychologyAmisulprideSulpiridePsychologyFactor Analysis Statisticalmedicine.drugAntipsychotic AgentsInternational clinical psychopharmacology
researchProduct

Brain density in depression: methodological and psychopathological aspects

1988

The relationship between brain density, measured by computerized tomography (CT), and severity of depression was investigated in 44 patients with a major depressive episode according to DSM-III. In order to limit methodological problems, correlations between both the Brief Psychiatric Rating Scale (BPRS) and the Bech-Rafaelsen Melancholia Scale (BRMS) with density values were controlled for age, different ventricle measurements, brain size, and density and size of the skull. The BRMS score correlated inversely with density of the right thalamus, the right head of the caudate, and with parietal grey matter and occipital regions of both hemispheres. Similar, but nonsignificant results, were o…

AdultMalePsychiatric Status Rating Scalesmedicine.medical_specialtyDepressionCaudate nucleusParietal lobeBrainAnatomyGrey matterAudiologyPsychiatry and Mental healthmedicine.anatomical_structureBrief Psychiatric Rating ScaleBrain sizemedicineHumansFemalemedicine.symptomTomography X-Ray ComputedOccipital lobeMajor depressive episodePsychologyDepression (differential diagnoses)Acta Psychiatrica Scandinavica
researchProduct

Multimodal morphometry and functional magnetic resonance imaging in schizophrenia and auditory hallucinations

2012

To validate a multimodal [structural and functional magnetic resonance (MR)] approach as coincidence brain clusters are hypothesized to correlate with clinical severity of auditory hallucinations.Twenty-two patients meeting Diagnostic and Statistical Manual of Mental Disorders (fourth edition, DSM-IV) criteria for schizophrenia and experiencing persistent hallucinations together with 28 healthy controls were evaluated with structural and functional MR imaging with an auditory paradigm designed to replicate those emotions related to the patients' hallucinatory experiences. Coincidence maps were obtained by combining structural maps of gray matter reduction with emotional functional increased…

medicine.medical_specialtyBrief Articlemedicine.diagnostic_testbusiness.industryMagnetic resonance imagingmacromolecular substancesAudiologyequipment and suppliesPsychotic symptom rating scaleBrief Psychiatric Rating ScalemedicineFunctional mrClinical severityPsychiatrybusinessFunctional magnetic resonance imaginghuman activitiesWorld Journal of Radiology
researchProduct

Homocysteine and MTHFR C677T polymorphism in children and adolescents with psychotic and mood disorders

2013

High level of homocysteine (Hcy) is risk factor of schizophrenia and mood disorders.The aim was to detect a serum level of Hcy, examine the associations between the level of Hcy, methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism and clinical properties for patients with schizophrenia, mood disorders and in a control group.There were 88 patients with schizophrenia, 28 with affective disorders and 94 from the control group. The Hamilton Anxiety Scale (HAM-A) was performed to study anxiety, the Hamilton Depression Scale (HAM-D) to study depression and the Brief Psychiatric Rating Scale (BPRS) to study severity of schizophrenia. The level of Hcy was stated by isocratic high-pe…

Malemedicine.medical_specialtyAdolescentHomocysteinePolymerase Chain Reactionbehavioral disciplines and activitieschemistry.chemical_compoundmental disordersBrief Psychiatric Rating ScalemedicineHumansRisk factorChildPsychiatryHomocysteineMethylenetetrahydrofolate Reductase (NADPH2)DNA PrimersPolymorphism GeneticBase SequencebiologyMood DisordersCase-control studymedicine.diseaseVitamin B 12Psychiatry and Mental healthchemistryMood disordersSchizophreniaCase-Control StudiesMethylenetetrahydrofolate reductaseSchizophreniabiology.proteinAnxietyFemalemedicine.symptomPsychologyNordic Journal of Psychiatry
researchProduct

Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic…

2021

Background Recent guidelines suggested a wider use of long-acting injectable antipsychotics (LAI) than previously, but naturalistic data on the consequences of LAI use in terms of discontinuation rates and associated factors are still sparse, making it hard for clinicians to be informed on plausible treatment courses. Objective Our objective was to assess, under real-world clinical circumstances, LAI discontinuation rates over a period of 12 months after a first prescription, reasons for discontinuation, and associated factors. Methods The STAR Network ‘Depot Study’ was a naturalistic, multicentre, observational prospective study that enrolled subjects initiating a LAI without restrictions …

MalePediatricsrespectively)0302 clinical medicineDelayed-Action PreparationBrief Psychiatric Rating ScalePharmacology (medical)he STAR Network ‘Depot Study’ prospectively followed 394 subjects initiating treatment with long-acting injections (LAIs) of antipsychotics under naturalistic conditions for 12 months. LAI discontinuation was frequent in everyday clinical practice in ItalyOriginal Research ArticleProspective StudiesProspective cohort studytreatmentMental DisordersHazard ratiowhereas more than half of participants initiating risperidone LAI and olanzapine LAI discontinued during the 12 months of follow-up (51.4 and 62.5%Psychiatric Status Rating ScaleMiddle Agedside efectsPsychiatry and Mental healthItalyMental DisorderFemalehe STAR Network ‘Depot Study’ prospectively followed 394 subjects initiating treatment with long-acting injections (LAIs) of antipsychotics under naturalistic conditions for 12 months. LAI discontinuation was frequent in everyday clinical practice in Italy occurring in almost 40% of the entire sample; side efects participant refusal to continue LAIs and LAIs no longer being required were the most frequently reported reasons for discontinuation. Paliperidone LAI and aripiprazole LAI were the least discontinued medications (33.9 and 35.4% respectively) whereas more than half of participants initiating risperidone LAI and olanzapine LAI discontinued during the 12 months of follow-up (51.4 and 62.5% respectively). In multivariate analysis being prescribed olanzapine LAI and poor medication adherence at baseline were signifcantly associated with higher discontinuation risk.HumanAntipsychotic Agentsmedicine.drugPsychopathologyAdultmedicine.medical_specialtyDiscontinuationFollow-Up StudieMedication Adherence03 medical and health sciencesmedicineHumansPaliperidoneAdverse effectSettore MED/25 - Psichiatriadiscontinuation ratesPsychiatric Status Rating Scalesrespectively). In multivariate analysisbusiness.industryLong-Acting Antipsychoticlong-acting injectable antipsychoticsSurvival AnalysisConfidence intervalparticipant refusal to continue LAIs and LAIs no longer being required were the most frequently reported reasons for discontinuation. Paliperidone LAI and aripiprazole LAI were the least discontinued medications (33.9 and 35.4%030227 psychiatryDiscontinuationProspective StudieAntipsychotic Agentoccurring in almost 40% of the entire sampleDelayed-Action PreparationsNeurology (clinical)business030217 neurology & neurosurgerybeing prescribed olanzapine LAI and poor medication adherence at baseline were signifcantly associated with higher discontinuation riskFollow-Up Studies
researchProduct

Spectroscopic metabolomic abnormalities in the thalamus related to auditory hallucinations in patients with schizophrenia

2008

Abstract Objective Previous studies have found neurochemical abnormalities in thalamic nuclei in patients with schizophrenia. These abnormalities have been associated with information processing deficiencies and symptom formation. There are no metabolic spectroscopy studies in patients with schizophrenia attending to auditory hallucinations. The aim of the present study is to explore metabolic Magnetic Resonance Spectroscopy (MRS) ratio differences in the thalamus between schizophrenic patients with and without auditory hallucinations and control subjects. Methods MRS studies (MRI 1.5 T unit) were performed in 49 patients with schizophrenia (30 with auditory hallucinations and 19 without au…

AdultMalePsychosismedicine.medical_specialtyMagnetic Resonance SpectroscopyHallucinationsThalamusAudiologyFunctional LateralityCholineThalamusBrief Psychiatric Rating ScalemedicineBrief Psychiatric Rating ScaleHumansBiological PsychiatryAspartic AcidAuditory hallucinationmedicine.diagnostic_testPositive and Negative Syndrome ScaleMagnetic resonance imagingCreatinemedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthSchizophreniaSchizophreniaAge of onsetmedicine.symptomPsychologyNeuroscienceSchizophrenia Research
researchProduct